Pharmaceutical Glass Packaging Market Analysis
The global pharmaceutical glass packaging market is anticipated to surpass USD 13.5 billion by 2027 and witness the highest CAGR of 6.9% by the end of 2026. Glass packaging is the safest way of packaging as the glass does not get contaminated and cause reactions. Additionally, as compared to conventional plastic packaging glass material can be recycled and reused and it exhibits various packaging-friendly properties such as sterility, chemical inertness, malleability, and water resistance.

The global pharmaceutical glass packaging market is anticipated to exhibit an incredible market expansion having the largest market value of USD 7.6 billion in 2020. The rising need for packaging, technological innovations, and demand for extending the shelf life of pharmaceutical products are expected to propel the overall growth of the global pharmaceutical industry. However, the major market restraint is increasing demand for plastic packaging as it has properties as safe to handle and lightweight. Furthermore, the rising need for pharmaceutical glass packaging in developing countries is set to offer lucrative growth opportunities for the players operating in the global pharmaceutical glass packaging market during the review period.

Market Segmentation
The global pharmaceutical glass packaging market has been classified into type, material, application, and region.
In terms of product type, the global pharmaceutical glass packaging market has been classified into vials, bottles & jars, cartridges & syringes, and ampoules. Based on material type, the pharmaceutical glass packaging market has been divided into type I, type II, and Type III. Based on application, the global market has been categorized into generic drugs, branded drugs, and biological drugs.

Regional Analysis
The region-specific analysis of the global pharmaceutical glass packaging market is studied across North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
North America is one of the noticeable regions for the pharmaceutical glass packaging market. The area has seen expanded interests in R&D and item development all things considered. Rigid guidelines and approaches in the US and Canada expanded utilization of medications, and quick development of the pharmaceutical area are the components driving the interest for pharmaceutical glass packaging in the locale. The US is the major market contributor of the global glass packaging market in North America.
In the US, the pharmaceutical glass packaging industry is seeing quick development. With the extending market for drugs, the interest in glass packaging increments persistently in the pharmaceutical business. Developing medical services spending is boosting the development of the pharmaceutical glass packaging market in the country.

Major Players
The leading players of the global pharmaceutical glass packaging market include Schott AG (Germany), Nipro Corporation (Japan), Piramal Glass (Mumbai), Sisecam Group (Tuzla, TR), Owens-Illinois Inc. (US) in 2019. Additionally, Gerresheimer AG (Germany), SGD Pharma (France), Bormioli Pharma S.p. (Italy), Ardagh Group S.A.(Luxembourg), West Pharmaceutical Services Inc. (US), and StoelzleOberglasGmbh (Austria) are developing as major players.

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.